The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-2-(5-(9H-purin-6-yl)-5-azaspiro[2.4]heptan-6-yl)-5-chloro-3-phenylquinazolin-4(3H)-one ID: ALA4760138
PubChem CID: 162658310
Max Phase: Preclinical
Molecular Formula: C25H20ClN7O
Molecular Weight: 469.94
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=c1c2c(Cl)cccc2nc([C@@H]2CC3(CC3)CN2c2ncnc3[nH]cnc23)n1-c1ccccc1
Standard InChI: InChI=1S/C25H20ClN7O/c26-16-7-4-8-17-19(16)24(34)33(15-5-2-1-3-6-15)22(31-17)18-11-25(9-10-25)12-32(18)23-20-21(28-13-27-20)29-14-30-23/h1-8,13-14,18H,9-12H2,(H,27,28,29,30)/t18-/m0/s1
Standard InChI Key: JMCOBLCEJSXBNG-SFHVURJKSA-N
Molfile:
RDKit 2D
34 40 0 0 0 0 0 0 0 0999 V2000
8.7250 -15.6793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0192 -16.0921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7295 -16.4969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1848 -14.6062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1837 -15.4258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8917 -15.8347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8899 -14.1974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5985 -14.6026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6019 -15.4233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3103 -15.8284 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0200 -15.4175 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0166 -14.5968 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3036 -14.1871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2991 -13.3700 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.7290 -15.8225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8166 -16.6350 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.6164 -16.8027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4746 -15.4881 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7218 -14.1867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4310 -14.5948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1370 -14.1847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1349 -13.3667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4210 -12.9604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7179 -13.3729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2128 -17.1833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4343 -16.9313 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8288 -17.4790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0006 -18.2788 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3855 -17.9786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7815 -18.5308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1201 -19.2759 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.9334 -19.1841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0973 -18.3824 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8875 -13.3802 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
1 3 1 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
8 13 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 1 0
13 14 2 0
15 16 1 0
16 17 1 0
17 2 1 0
2 18 1 0
18 15 1 0
15 11 1 6
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
12 19 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 30 1 0
29 25 1 0
16 25 1 0
29 30 2 0
30 31 1 0
31 32 1 0
32 33 2 0
33 29 1 0
7 34 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 469.94Molecular Weight (Monoisotopic): 469.1418AlogP: 4.44#Rotatable Bonds: 3Polar Surface Area: 92.59Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.83CX Basic pKa: 3.06CX LogP: 4.26CX LogD: 4.26Aromatic Rings: 5Heavy Atoms: 34QED Weighted: 0.42Np Likeness Score: -0.68
References 1. Tao Q,Chen Y,Liang X,Hu Y,Li J,Fang F,Wang H,Meng C,Liang J,Ma X,Gui S. (2020) Structurally novel PI3Kδ/γ dual inhibitors characterized by a seven-membered spirocyclic spacer: The SARs investigation and PK evaluation., 191 [PMID:32078865 ] [10.1016/j.ejmech.2020.112143 ] 2. Liu K, Li D, Zheng W, Shi M, Chen Y, Tang M, Yang T, Zhao M, Deng D, Zhang C, Liu J, Yuan X, Yang Z, Chen L.. (2021) Discovery, Optimization, and Evaluation of Quinazolinone Derivatives with Novel Linkers as Orally Efficacious Phosphoinositide-3-Kinase Delta Inhibitors for Treatment of Inflammatory Diseases., 64 (13.0): [PMID:34138567 ] [10.1021/acs.jmedchem.1c00004 ]